We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medica Group Plc | LSE:MGP | London | Ordinary Share | GB00BYV24996 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 211.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMGP
RNS Number : 2640H
Medica Group PLC
02 December 2020
Medica Group PLC
Director / PDMR Transaction and Shareholding
Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Dr Stephen Davies, Medical Director and Responsible Officer of Medica, that on 30 November 2020 he transferred a total of 521,032 ordinary shares of 0.2p in the Company ("Shares") to his wife, Mary Davies, for nil consideration. In addition, Stephen Davies and his wife have sold a total of 1,079,292 ordinary shares at a price of 120.00p per share.
Following these transactions, Stephen Davies has an interest in 576,634 shares, representing 0.5% of the issued share capital of the Company.
Furthermore, the Company also received a notification from Dr Stuart Quin, Chief Executive Officer of Medica Group PLC, that on 1 December 2020 he transferred a total of 60,000 ordinary shares of 0.2p in the Company ("Shares") to his wife Mallika Quin, for nil consideration. Following this transaction, there has been no change in the number of shares in which Stuart Quin has an interest.
The Notification of Dealing Forms for Dr Stephen Davies and Dr Stuart Quin can be found below.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.
Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Dr Stephen Davies ---------------------------- --------------------------------------------------- 2 Reason for the notification --------------------------------------------------------------------------------- a) Position/status Medical Director and Responsible Officer/PDMR ---------------------------- --------------------------------------------------- b) Initial notification Initial notification /Amendment ---------------------------- --------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --------------------------------------------------------------------------------- a) Name Medica Group PLC ---------------------------- --------------------------------------------------- b) LEI 213800B8XE5FUSZF5Z16 ---------------------------- --------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --------------------------------------------------------------------------------- a) Description of the Ordinary shares of 0.2p financial instrument, type of instrument GB00BYV24996 b) Nature of the transaction Transfer of Ordinary Shares to Mary Davies ---------------------------- --------------------------------------------------- c) Price(s) and volume(s) Price Volumes (s) (s) N/A 521,032 -------- ---------------------------- --------------------------------------------------- d) Aggregated information * Aggrated volume 521,032 N/A * Price e) Date of the transaction 30 November 2020 f) Place of the transaction Outside a trading venue ---------------------------- --------------------------------------------------- Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Dr Stephen Davies ---------------------------- ---------------------------------------------- 2 Reason for the notification ---------------------------------------------------------------------------- a) Position/status Medical Director and Responsible Officer/PDMR ---------------------------- ---------------------------------------------- b) Initial notification Initial notification /Amendment ---------------------------- ---------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------------------- a) Name Medica Group PLC ---------------------------- ---------------------------------------------- b) LEI 213800B8XE5FUSZF5Z16 ---------------------------- ---------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------------------- a) Description of the Ordinary shares of 0.2p financial instrument, type of instrument GB00BYV24996 b) Nature of the transaction Market sale ---------------------------- ---------------------------------------------- c) Price(s) and volume(s) Price (s) Volumes (s) GBP 120.00 1,031,924 ---------- d) Aggregated information * Aggrated volume 1,031,924 GBP 120.00 * Price e) Date of the transaction 30 November 2020 f) Place of the transaction XLON ---------------------------- ---------------------------------------------- Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Mary Davies ---------------------------------- ------------------------------------------- 2 Reason for the notification ------------------------------------------------------------------------------- a) Position/status PCA/ Dr Stephen Davies (Medical Director and Responsible Officer) ---------------------------------- ------------------------------------------- b) Initial notification Initial notification /Amendment ---------------------------------- ------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------- a) Name Medica Group PLC ---------------------------------- ------------------------------------------- b) LEI 213800B8XE5FUSZF5Z16 ---------------------------------- ------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------- a) Description of the Ordinary shares of 0.2p financial instrument, type of instrument GB00BYV24996 b) Nature of the transaction Market sale ---------------------------------- ------------------------------------------- c) Price(s) and volume(s) Price (s) Volumes (s) GBP 120.00 47,368 -------- d) Aggregated information * Aggrated volume 47,368 GBP 120.00 * Price e) Date of the transaction 30 November 2020 f) Place of the transaction XLON ---------------------------------- ------------------------------------------- Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Dr Stuart Quin ---------------------------- --------------------------------------- 2 Reason for the notification --------------------------------------------------------------------- a) Position/status Chief Executive Officer/PDMR ---------------------------- --------------------------------------- b) Initial notification Initial notification /Amendment ---------------------------- --------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --------------------------------------------------------------------- a) Name Medica Group PLC ---------------------------- --------------------------------------- b) LEI 213800B8XE5FUSZF5Z16 ---------------------------- --------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions
have been conducted --------------------------------------------------------------------- a) Description of the Ordinary shares of 0.2p financial instrument, type of instrument GB00BYV24996 b) Nature of the transaction Transfer of Ordinary Shares to Mallika Quin ---------------------------- --------------------------------------- c) Price(s) and volume(s) Price Volumes (s) (s) GBP 0 60,000 -------- ---------------------------- --------------------------------------- d) Aggregated information * Aggrated volume 60,000 GBP 0 * Price e) Date of the transaction 1 December 2020 f) Place of the transaction Outside a trading venue ---------------------------- ---------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKKBBBCBDKKBK
(END) Dow Jones Newswires
December 02, 2020 04:31 ET (09:31 GMT)
1 Year Medica Chart |
1 Month Medica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions